[{"address1": "103 Carnegie Center", "address2": "Suite 300", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "818-839-4378", "website": "https://www.acastipharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Prashant  Kohli", "age": 51, "title": "CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 599970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Amresh  Kumar Ph.D.", "age": 43, "title": "VP of Program Management", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 353502, "exercisedValue": 0, "unexercisedValue": 8243}, {"maxAge": 1, "name": "Ms. Carrie  D'Andrea", "age": 51, "title": "VP of Clinical Operations", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 359051, "exercisedValue": 0, "unexercisedValue": 8243}, {"maxAge": 1, "name": "Mr. Robert J. DelAversano CPA", "age": 51, "title": "VP of Finance and Principal Financial & Accounting Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. R. Loch MacDonald M.D., Ph.D.", "age": 61, "title": "Member of Scientific Advisory Board & Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 3.05, "open": 3.0, "dayLow": 3.0, "dayHigh": 3.05, "regularMarketPreviousClose": 3.05, "regularMarketOpen": 3.0, "regularMarketDayLow": 3.0, "regularMarketDayHigh": 3.05, "beta": 1.515, "forwardPE": -2.3828125, "volume": 3467, "regularMarketVolume": 3467, "averageVolume": 20395, "averageVolume10days": 56640, "averageDailyVolume10Day": 56640, "marketCap": 30926694, "fiftyTwoWeekLow": 1.98, "fiftyTwoWeekHigh": 3.59, "fiftyDayAverage": 2.5958, "twoHundredDayAverage": 2.8558, "currency": "USD", "enterpriseValue": 11517576, "floatShares": 4646389, "sharesOutstanding": 10139900, "sharesShort": 3862, "sharesShortPriorMonth": 517, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.38391, "heldPercentInstitutions": 0.21226999, "shortRatio": 0.27, "shortPercentOfFloat": 0.0005, "impliedSharesOutstanding": 10139900, "bookValue": 5.855, "priceToBook": 0.5209223, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -11447000, "trailingEps": -1.43, "forwardEps": -1.28, "lastSplitFactor": "1:6", "lastSplitDate": 1688947200, "enterpriseToEbitda": -0.868, "52WeekChange": 0.18217051, "SandP52WeekChange": 0.34083736, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ACST", "underlyingSymbol": "ACST", "shortName": "Acasti Pharma, Inc.", "longName": "Acasti Pharma Inc.", "firstTradeDateEpochUtc": 1328625000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b85d19b3-5615-3119-8c13-5a148ac836a8", "messageBoardId": "finmb_47663822", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.05, "targetHighPrice": 7.99, "targetLowPrice": 7.99, "targetMeanPrice": 7.99, "targetMedianPrice": 7.99, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 19409000, "totalCashPerShare": 1.914, "ebitda": -13266000, "quickRatio": 7.618, "currentRatio": 7.857, "returnOnAssets": -0.116210006, "returnOnEquity": -0.18556999, "freeCashflow": -5580375, "operatingCashflow": -9689000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]